Alimetry Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$18.5M
- Investors
-
17
Alimetry General Information
Description
Developer of a symptom-tracking and real-time gastric monitoring device designed for investigating gastric disorders. The company's device detects the underlying motility of the stomach to identify the contributing causes of common symptoms, such as abdominal pain, indigestion, nausea, and vomiting, enabling patients to receive improved gastrointestinal care.
Contact Information
Website
www.alimetry.comCorporate Office
- 86 Symonds Street
- Auckland, 1010
- New Zealand
Corporate Office
- 86 Symonds Street
- Auckland, 1010
- New Zealand
Alimetry Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 24-Oct-2024 | $18.5M | Completed | Generating Revenue | ||
| 7. Accelerator/Incubator | 01-Jul-2022 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 02-Mar-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 10-Dec-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | Completed | Startup | ||||
| 3. Grant | 02-Oct-2019 | Completed | Startup | |||
| 2. Seed Round | 01-Oct-2019 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Alimetry Patents
Alimetry Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026220377-A1 | Integrated diagnostic system and methods for simultaneous body surface gastric mapping and ph impedance testing in gastroesophageal reflux disease | Pending | 18-Apr-2025 | ||
| WO-2026154424-A1 | Guided report interpretation using large language model | Pending | 17-Jan-2025 | ||
| US-20260144475-A1 | Body surface gastric mapping artifact removal and correction methods and systems | Pending | 25-Nov-2024 | ||
| WO-2026110128-A1 | Body surface gastric mapping artifact removal and correction methods and systems | Pending | 25-Nov-2024 | ||
| US-20250352111-A1 | Systems and methods for body surface colonic mapping | Pending | 16-May-2024 | A61B5/392 |
Alimetry Signals
Alimetry Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Gastroenterological Association | Corporation | Minority | ||
| Cerity Partners Ventures | Corporate Venture Capital | Minority | ||
| Icehouse Ventures | Venture Capital | Minority | ||
| Olympus Innovation Ventures | Corporate Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority |
Alimetry FAQs
-
When was Alimetry founded?
Alimetry was founded in 2019.
-
Where is Alimetry headquartered?
Alimetry is headquartered in Auckland, New Zealand.
-
What is the size of Alimetry?
Alimetry has 49 total employees.
-
What industry is Alimetry in?
Alimetry’s primary industry is Monitoring Equipment.
-
Is Alimetry a private or public company?
Alimetry is a Private company.
-
What is the current valuation of Alimetry?
The current valuation of Alimetry is .
-
What is Alimetry’s current revenue?
The current revenue for Alimetry is .
-
How much funding has Alimetry raised over time?
Alimetry has raised $31.7M.
-
Who are Alimetry’s investors?
American Gastroenterological Association, Cerity Partners Ventures, Icehouse Ventures, Olympus Innovation Ventures, and MedTech Innovator are 5 of 17 investors who have invested in Alimetry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process